Skip to main content
. 2016 Sep 9;107(10):1527–1538. doi: 10.1111/cas.13013

Table 6.

Relationships between YAP1 expression levels and clinicopathological factors in 71 high‐grade neuroendocrine tumors

YAP1 expression P‐value
Positive Negative
Pathological stage
Stage I 7 25 >0.9999
Stages II–IV 5 21
T‐stage
T1 5 22 >0.9999
T2, T3, T4 8 35
Nodal involvement§
Positive 2 19 0.1817
Negative 10 28
Lymphatic invasion
Positive 2 31 0.1239
Negative 6 21
Vessel invasion††
Positive 7 40 >0.9999
Negative 1 11
Pleural invasion‡‡
Positive 10 26 0.0658
Negative 3 30
Tumor size, cm§§
<3 7 36 0.5351
≥3 6 20
Pulmonary metastasis¶¶
Positive 1 3 0.5751
Negative 12 53
Age, years
<60 1 8 >0.9999
≥60 12 50
Sex
Male 9 55 0.0183
Female 4 3

†Stages (I or II–IV) of 13 cases were unknown. ‡Pathological T‐stage of one case was unknown. §Presence or absence of nodal involvement in 12 cases was unknown. ¶Presence or absence of lymphatic invasion in 11 cases was unknown. ††Presence or absence of vessel invasion in 11 cases was unknown. ‡‡Presence or absence of pleural invasion in two cases was unknown. §§Tumor sizes of two cases were unknown. ¶¶Presence or absence of pulmonary metastasis in two cases was unknown. Underlined P‐values are considered significant (P < 0.05).